Previous issue | Volume 92 | ESPE2019

58th Annual ESPE meeting

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

Card image cap
The theme of this year’s meeting is Variety and Variation in Paediatric Endocrinology. Join us in Vienna to explore the diversity we encounter in our discipline and the care that we have to exercise when using the term “normality”. Whilst gaining an update on the latest treatments, clinical best practice and cutting edge research in the field of paediatric endocrinology.

Poster Category 1

Diabetes and Insulin

A Case of Neonatal Diabetes with Hyperferritinemia: A Distal PTF1A Enhancer Mutation
1Division of Pediatric Endocrinology, Health Sciences University, Dr. Behcet Uz Child Disease and Pediatric Surgery Training and Research Hospital, Izmir, Turkey. 2Department of Molecular Genetics, Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom
Elevated Anti-tissue Transglutaminase Antibodies in Children Newly Diagnosed with type 1 Diabetes do not Always Indicate Celiac Disease
1Dokuz Eylul University, Faculty of Medicine, Department of Pediatric Endocrinology, İzmir, Turkey. 2Dokuz Eylul University, Faculty of Medicine, Department of Pediatrics, İzmir, Turkey
Effects of Glypican-4 Protein on INS1E Cell Viability and Insulin Signalling
1Center for Pediatric Research Leipzig, University Hospital for Children and Adolescents, Leipzig University, Leipzig, Germany. 2Institute for Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom. 3LIFE Leipzig Research Center for Civilization Diseases, Leipzig University, Leipzig, Germany
Dual Diagnosis of Type 1 Diabetes and ADHD
1Safra's Children Hospital, Sheba Medical Center, Pediatric Endocrinology & Diabetes Unit, Ramat Gan, Israel. 2Maccabi Health Care Services, National Juvenile Diabetes Clinic, Raanana, Israel. 3Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel. 4Wolfson Medical Center, Pediatric Diabetes & Endocrine Unit, Holon, Israel. 5Ben-Gurion University of the Negev, The Department of Software and Information System Engineering, Beer Sheva, Israel. 6Barzilai Medical Center, The Pediatric Department, Ashkelon, Israel. 7Ben-Gurion University of the Negev, The Goldman School of Medicine, Beer Sheva, Israel
Heterozygous RFX6 Mutation as a Cause of Diabetes Mellitus in a Multigenerational Family
1Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel. 2The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. 3The Genetics institute, Rambam Health Care Campus, Haifa, Israel. 4Meuhedet Health services, Umm El Fahem, Israel
Plasma Tocopherols and Carotenes are Decreased in Spanish Children and Adolescents with Insulin Resistance, Independently of Obesity
1Growth, Exercise, NUtrition and Development (GENUD) Research Group, Universidad de Zaragoza, Health Research Institute of Aragón (ISS Aragón), Food and Agriculture Institute of Aragón (IA2), Zaragoza, Spain. 2Paediatric Department, Lozano Blesa University Hospital, University of Zaragoza, Food and Agriculture Institute of Aragón (IA2), Zaragoza, Spain. 3Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. 4Galicia Nutrition, Growth and Human Development Research Unit, Pediatric Department; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS); Universidad de Santiago de Compostela, Santiago de Compostela, Spain. 5Paediatric Research and Metabolism Unit, Hospital Universitario Reina Sofia; Instituto Maimónides de Investigación Biomédica (IMBIC), Córdoba, Spain. 6Department of Biochemistry and Molecular Biology II, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Granada; Instituto de Investigación Biosanitaria ibs, Granada, Spain
Serum Dipeptidyl peptidase-4 Activity and its Relation to Insulin Resistance in Type 1 Diabetic Adolescents
1The Diabetes Endocrine and Metabolism Pediatric Unit (DEMPU), Pediatric Department, Faculty of Medicine, Cairo University, Cairo, Egypt. 2Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. 3Pediatric Department, Faculty of Medicine, Kafr Elsheikh University, Kafr Elsheikh, Egypt
Expression of Receptor for Advanced Glycation End-products and its Ligands HMGB1 and s100A12 in Children and Adolescents with New-onset Type 1 Diabetes and in Patients with Longer Disease Duration
1University Hospital Centre Zagreb, Zagreb, Croatia. 2School of medicine, University of Zagreb, Zagreb, Croatia. 3Clinic for Children's Diseases Zagreb, Zagreb, Croatia
The Factors Associated with High Levels of HbA1C in Children and Young People with Type 1 Diabetes Mellitus
Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom